Imprimis completes registered public offering

Drug delivery company and compounding pharmacy Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY) raised $3.1 million through the sale of 1.3 million shares at $2.40 in a registered direct offering on March ...